255 related articles for article (PubMed ID: 32366719)
1. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
Pereira RS; Malvezi AD; Lovo-Martins MI; Lucchetti BFC; Santos JP; Tavares ER; Verri WA; de Almeida Araújo EJ; Yamauchi LM; Yamada-Ogatta SF; Martins-Pinge MC; Pinge-Filho P
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366719
[TBL] [Abstract][Full Text] [Related]
2. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
[TBL] [Abstract][Full Text] [Related]
3. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
4. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection.
Barbosa JMC; Pedra-Rezende Y; Mata-Santos HA; Vilar-Pereira G; Melo TG; Ramos IP; Gibaldi D; Moreira OC; Nunes DF; Batista MM; Lannes-Vieira J; Daliry A; Salomão K
Biomed Pharmacother; 2024 Jun; 175():116742. PubMed ID: 38754265
[TBL] [Abstract][Full Text] [Related]
6. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
7. Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.
Assíria Fontes Martins T; de Figueiredo Diniz L; Mazzeti AL; da Silva do Nascimento ÁF; Caldas S; Caldas IS; de Andrade IM; Ribeiro I; Bahia MT
PLoS One; 2015; 10(6):e0128707. PubMed ID: 26076455
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.
Campos-Estrada C; Liempi A; González-Herrera F; Lapier M; Kemmerling U; Pesce B; Ferreira J; López-Muñoz R; Maya JD
PLoS Negl Trop Dis; 2015 May; 9(5):e0003770. PubMed ID: 25978361
[TBL] [Abstract][Full Text] [Related]
9. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
10. Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
Silva Grijó Farani P; Iandra da Silva Ferreira B; Begum K; Vilar-Pereira G; Pereira IR; Fernández-Figueroa EA; Cardenas-Ovando RA; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011223. PubMed ID: 36972298
[TBL] [Abstract][Full Text] [Related]
11. Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
Vilar-Pereira G; Castaño Barrios L; Silva AAD; Martins Batista A; Resende Pereira I; Cruz Moreira O; Britto C; Mata Dos Santos HA; Lannes-Vieira J
PLoS One; 2021; 16(1):e0244710. PubMed ID: 33400707
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
[TBL] [Abstract][Full Text] [Related]
13. The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi.
Leite ALJ; Paula Costa G; Lopes LR; Reis Mota LWD; Vieira PMA; Talvani A
Acta Trop; 2017 Oct; 174():136-145. PubMed ID: 28720491
[TBL] [Abstract][Full Text] [Related]
14. Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.
Vilar-Pereira G; Resende Pereira I; de Souza Ruivo LA; Cruz Moreira O; da Silva AA; Britto C; Lannes-Vieira J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4297-309. PubMed ID: 27161638
[TBL] [Abstract][Full Text] [Related]
15. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
[TBL] [Abstract][Full Text] [Related]
16. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
[TBL] [Abstract][Full Text] [Related]
19. An update on benznidazole for the treatment of patients with Chagas disease.
Thakare R; Dasgupta A; Chopra S
Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
